Core Viewpoint - The successful IPO of Jianfa Zhixin marks a significant milestone for the company, which is a leading player in the medical device supply chain management sector, reflecting its strong market position and innovative service model [1][9]. Company Overview - Jianfa Zhixin has been approved for its IPO on the Shenzhen Stock Exchange with an initial price of 7.05 yuan per share, opening at 36.00 yuan, representing a 427% increase on the first day [1]. - The company focuses on enhancing the efficiency of medical device distribution and has developed an integrated service system covering direct sales, distribution, and SPD (supply chain management) services [2][3]. Business Model and Innovation - The company employs a unique "direct sales + distribution + SPD" model, which strengthens its competitive edge by enhancing customer loyalty and operational efficiency [3]. - Jianfa Zhixin is committed to digitalization and precision management, which drives service enhancement and operational improvements, allowing clients to reduce costs and increase efficiency [4][6]. - The SPD service represents a shift from traditional distribution to high-value service output, embedding the company deeply into hospital operations and creating long-term partnerships [5][9]. Financial Performance - In the first half of 2025, Jianfa Zhixin reported a revenue of 9.829 billion yuan, a 12.2% increase year-on-year, and a net profit of 137 million yuan, up 42.4% [7]. - The company's total assets reached 13.885 billion yuan, a 5.9% increase from the end of 2024, indicating a robust capital structure and operational efficiency [7]. - Cash flow from operating activities improved significantly, narrowing the net cash outflow to 139 million yuan from 393 million yuan in the previous year, attributed to better management of accounts receivable and inventory turnover [8]. Industry Context - The medical device distribution industry is undergoing structural upgrades due to increased demand for efficient and centralized operations amid cost control measures in hospitals [8][9]. - The implementation of UDI (Unique Device Identification) is raising standards for supply chain information and compliance, benefiting leading companies like Jianfa Zhixin that possess technological advantages [8][9].